Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sara J Terpening"'
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 9, Pp 883-894 (2017)
Introduction: Rapid development and production of vaccines against emerging diseases requires well established, validated, robust technologies to allow industrial scale production and accelerated licensure of products. Areas covered: A versatile Vero
Externí odkaz:
https://doaj.org/article/a26917a1de6c4d3d95e7b0adb5724657
Autor:
Juan Daniel Martínez, Nancy A. Niemuth, Emily S Syar, Shauna Farr-Jones, Roy E. Barnewall, Milan T. Tomic, Ronald R. Cobb, Doris M Snow, Dean J. Kobs, Isaac Finger-Baker, Sara J Terpening, James D. Marks, Laura J. Collins
Publikováno v:
Toxins
Toxins, vol 13, iss 1
Toxins, Vol 13, Iss 31, p 31 (2021)
Volume 13
Issue 1
Toxins, vol 13, iss 1
Toxins, Vol 13, Iss 31, p 31 (2021)
Volume 13
Issue 1
Botulinum neurotoxins (BoNT) are extremely potent and can induce respiratory failure, requiring long-term intensive care to prevent death. Recombinant monoclonal antibodies (mAbs) hold considerable promise as BoNT therapeutics and prophylactics. In c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd35116ff386f67a9b956136b6e08dcd
https://pubmed.ncbi.nlm.nih.gov/33466411
https://pubmed.ncbi.nlm.nih.gov/33466411
Publikováno v:
Expert review of vaccines. 16(9)
Rapid development and production of vaccines against emerging diseases requires well established, validated, robust technologies to allow industrial scale production and accelerated licensure of products. Areas covered: A versatile Vero cell platform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3149ce081af6da7b4cf140b0f978b71
https://pubmed.ncbi.nlm.nih.gov/28724343
https://pubmed.ncbi.nlm.nih.gov/28724343
Autor:
John P. Bader, Nicola Mongelli, Rebecca Kiser, Robert W. Buckheit, Robert R. Schultz, David J. Clanton, Sara J. Terpening, Ven Narayanan, Andrea Lombardi Borgia, William G. Rice
Publikováno v:
Antiviral Research. 27:335-354
A series of novel distamycin-related polyanionic compounds were compared for their anti-HIV activity. Several were highly potent inhibitors of HIV virus-induced cell killing and viral replication of a wide variety of laboratory isolates, as well as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::493ceec5206f60f234eb607f6e9601a9
https://doi.org/10.1016/0166-3542(95)00017-g
https://doi.org/10.1016/0166-3542(95)00017-g
Autor:
Brian A. Roberts, Sara J. Terpening, Robert V. House, Donald L. Fine, Jason M. Mott, Daphne Vasconcelos
Publikováno v:
Vaccine. 26(27-28)
Assessment of neurovirulence is a standard test for vaccines derived from virulent neurotropic viruses. This study evaluated the potential neurovirulence of V3526, a live attenuated vaccine derived from a full-length infectious clone of Venezuelan eq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7f16f9d0f5684b888b5ca89b989f913
https://pubmed.ncbi.nlm.nih.gov/18508163
https://pubmed.ncbi.nlm.nih.gov/18508163
Autor:
Janae L. Raetz, Sara J. Terpening, Ann M. Powers, Dale C. Baker, Donald L. Fine, Cindy L. H. Kelly, Brian A. Roberts, Max L. Teehee, Richard A. Bowen
Publikováno v:
Vaccine. 25(10)
A new vaccine, V3526, is a live-attenuated virus derived by site-directed mutagenesis from a virulent clone of the Venezuelan equine encephalitis virus (VEEV) IA/B Trinidad donkey (TrD) strain, intended for human use in protection against Venezuelan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d7adb3e2f06a5c0803764e420bc04e1
https://pubmed.ncbi.nlm.nih.gov/17240002
https://pubmed.ncbi.nlm.nih.gov/17240002
A cell culture process adaptable to produce smallpox vaccine at large scale has been developed. To achieve this, Design of Experiments (DOE) was applied to identify and optimize critical cell culture process parameters for MRC-5 cell growth and recov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e25a94673774e6763162bd8627ea21a
https://europepmc.org/articles/PMC3449906/
https://europepmc.org/articles/PMC3449906/
Publikováno v:
Journal of virological methods. 58(1-2)
A biologically contained cytoprotection assay was developed to screen inhibitors of the human immunodeficiency virus without the need for high level containment or practices. The virus used has multiple point mutations that have destroyed its ability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f072459c9e11f7fc2bad31a1b6960b
https://pubmed.ncbi.nlm.nih.gov/8783155
https://pubmed.ncbi.nlm.nih.gov/8783155